Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Counterpoint: were industry-sponsored roflumilast trials appropriate? No.

× No keyword cloud information.

20 in total

1. Randomized clinical trials in HEPATOLOGY: predictors of quality.

Authors: L L Kjaergard; D Nikolova; C Gluud
Journal: Hepatology Date: 1999-11 Impact factor: 17.425

2. Reporting and dissemination of industry versus non-profit sponsored economic analyses of six novel drugs used in oncology.

Authors: K S Knox; J R Adams; B Djulbegovic; T J Stinson; C Tomor; C L Bennet
Journal: Ann Oncol Date: 2000-12 Impact factor: 32.976

3. The uncertainty principle and industry-sponsored research.

Authors: B Djulbegovic; M Lacevic; A Cantor; K K Fields; C L Bennett; J R Adams; N M Kuderer; G H Lyman
Journal: Lancet Date: 2000-08-19 Impact factor: 79.321

Review 4. Pharmaceutical industry sponsorship and research outcome and quality: systematic review.

Authors: Joel Lexchin; Lisa A Bero; Benjamin Djulbegovic; Otavio Clark
Journal: BMJ Date: 2003-05-31

Review 5. Scope and impact of financial conflicts of interest in biomedical research: a systematic review.

Authors: Justin E Bekelman; Yan Li; Cary P Gross
Journal: JAMA Date: 2003 Jan 22-29 Impact factor: 56.272

6. Side-effects of roflumilast.

Authors: Steve Gupta
Journal: Lancet Date: 2012-02-25 Impact factor: 79.321

7. Inhaled corticosteroids in COPD: the case against.

Authors: S Suissa; P J Barnes
Journal: Eur Respir J Date: 2009-07 Impact factor: 16.671

8. Mega-trials for blockbusters.

Authors: John P A Ioannidis
Journal: JAMA Date: 2013-01-16 Impact factor: 56.272

9. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials.

Authors: Leonardo M Fabbri; Peter M A Calverley; José Luis Izquierdo-Alonso; Daniela S Bundschuh; Manja Brose; Fernando J Martinez; Klaus F Rabe
Journal: Lancet Date: 2009-08-29 Impact factor: 79.321

10. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials.

Authors: Peter M A Calverley; Klaus F Rabe; Udo-Michael Goehring; Søren Kristiansen; Leonardo M Fabbri; Fernando J Martinez
Journal: Lancet Date: 2009-08-29 Impact factor: 79.321

1 in total

1. Response.

Authors: Jason Rho; Nancy Ho; Vinay Prasad
Journal: Chest Date: 2015-07 Impact factor: 9.410

1 in total